Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (5967)	11/17/1998 5:58:00 PM
From: Bluegreen	Read Replies (1) \| Respond to of 9719

I thought someone might have seen improvement on something like deep cystic scaring acne of back and shoulders or other dermatological disorders while being in trials for K sarcs.

To: Vector1 who wrote (5967)	11/18/1998 3:51:00 PM
From: Vector1	Read Replies (1) \| Respond to of 9719

All VDers, Any views on NABI one of the largest suppliers of source plasma and specialty plasma. They collect the plasma through 78 collection centers and are in development on a number of proprietary products. The specialty products include H-BIG which provides passive immunity to hepatitis B. The company is highly leveraged with $60 million in subordinated bonds and about $40m in bank debt. They are loosing money and appear to be having production problems. There are 35 million shares. Is this a candidate to short. V1